Device manufacturer, as written on reports
Abbott Medical Crm-Sylmar: medical device reports filed with FDA
11,302 reports name it as the manufacturer of the device involved, 2026–2026.
- 11,302
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 11,302
- reports, 12 months to August 2026
- 0 in the 12 months before
- 57.7%
- classified as malfunction
- 62.3% across all reports
- 2%
- classified as death, as reported
- 0.9% across all reports
11,302 medical device reports received by FDA give Abbott Medical Crm-Sylmar as the manufacturer of the device involved, 0% of the MAUDE database, from February 2026 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
11,302 reports arrived in the 12 months to August 2026, with none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (57.7%), injury (40.2%) and death (2%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Tendril Sts | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 1,796 | 4,320 | 3.1% |
| Assurity Mri | Implantable pulse generator, pacemaker (non-crt) | 884 | 2,035 | 1.8% |
| Gallant HF | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 809 | 1,918 | 0.7% |
| Durata Sts Optim Active Fixation Df-4 Connector | Permanent defibrillator electrodes | 695 | 1,784 | 3.9% |
| Aveir Leadless Pacemaker, Right Ventricle | Leadless pacemaker | 676 | 1,372 | 3.9% |
| Assert-IQ ICM | Recorder, event, implantable cardiac, (without arrhythmia detection) | 541 | 1,162 | 0% |
| AVEIR AR 2 Leadless Pacemaker | Leadless pacemaker | 401 | 519 | 1.3% |
| Quartet | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 355 | 848 | 5.2% |
| UltiPace Lead, 52cm MRI | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 344 | 673 | 1.8% |
| UltiPace Lead, 65cm MRI | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 272 | 638 | 0.7% |
| Optisure Active Fixation Df-4 Connector | Permanent defibrillator electrodes | 260 | 623 | 4.3% |
| Aveir Delivery Catheter | Leadless pacemaker | 239 | 433 | 11.8% |
| Quadra Assura MP ICD | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 200 | 507 | 2.1% |
| UltiPace Lead, 58cm MRI | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 191 | 427 | 1.2% |
| Tendril Sdx Lead | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 189 | 431 | 4.5% |
| Tendril St | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 188 | 547 | 5.2% |
| Tendril Mri | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 176 | 422 | 4.1% |
| Isoflex Optim Lead | Permanent defibrillator electrodes | 174 | 437 | 2% |
| Durata Sts Optim Active Fixation | Implantable cardioverter defibrillator (non-crt) | 131 | 301 | 5.6% |
| Aveir Leadless Pacemaker, Right Atrium | Leadless pacemaker | 130 | 523 | 1.4% |
| Neutrino NxT HF | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 130 | 331 | 0.6% |
| UltiPace Lead, 46cm MRI | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 99 | 184 | 0.9% |
| Gallant VR | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 95 | 245 | 2% |
| Quadra Allure MP CRT-P | Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p) | 85 | 205 | 2.2% |
| Unify Assura CRT-D RF HV | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 75 | 186 | 3.7% |
| Fortify Assura VR ICD, US | Implantable cardioverter defibrillator (non-crt) | 67 | 213 | 2.3% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| NVN | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 3,417 | 30.2% |
| NIK | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 2,424 | 21.4% |
| PNJ | Leadless pacemaker | 1,481 | 13.1% |
| NVY | Permanent defibrillator electrodes | 1,271 | 11.2% |
| LWP | Implantable pulse generator, pacemaker (non-crt) | 1,007 | 8.9% |
| MXC | Recorder, event, implantable cardiac, (without arrhythmia detection) | 593 | 5.2% |
| NVZ | Pulse generator, permanent, implantable | 426 | 3.8% |
| LWS | Implantable cardioverter defibrillator (non-crt) | 388 | 3.4% |
| OJX | Drug eluting permanent left ventricular (lv) pacemaker electrode | 102 | 0.9% |
| NKE | Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p) | 90 | 0.8% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Abbott Medical Crm-Sylmar reports
How many FDA device reports name Abbott Medical Crm-Sylmar as manufacturer?
11,302 reports through August 2026, 11,302 of them in the latest 12 months.
Which of its brands appear most often?
Tendril Sts (1,796), Assurity Mri (884), Gallant HF (809), Durata Sts Optim Active Fixation Df-4 Connector (695) and Aveir Leadless Pacemaker, Right Ventricle (676).
Which device types does it report on?
drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes (30.2%), defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) (21.4%), leadless pacemaker (13.1%) and permanent defibrillator electrodes (11.2%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.